Joachim Koch

Joachim Koch

Company: Affimed GmbH

Job title: Head Translational Reseach & Innovaiton


Prof. Dr. Joachim Koch joined Affimed in 2016 and is currently head of Translational Research & Innovation. Prior to Affimed, Joachim led the Immunobiology of Natural Killer Cells group, a research group focusing on NK cell tumor immunosurveillance, at the Institute of Tumor Biology and Experimental Therapy (Georg-Speyer-Haus), Frankfurt a. M., and University of Mainz Medical Center. A biologist trained at University of Cologne and Harvard Medical School, Joachim holds a Ph.D. from the University of Heidelberg. Following his Habilitation on viral immune evasion from MHC class I antigen presentation at Goethe-University Frankfurt and at LUMC Leiden, Joachim was granted a Professorship in Biochemistry at Goethe-University Frankfurt.


Creating New Treatment Options for Patients Through the Activation & Redirection of Innate Immune Cells 10:10 am

Highlighting how tumor immune evasion strategies lead to disarming of innate immunity by the tumor Demonstrating that through the activation and redirection of innate immune cells, innate cell engagers (ICEs) can restore immunosurveillance providing clinical benefit in heavily pre-treated patients suffering from hematological malignancies High NK cell counts prior and during treatment with ICEs is…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.